Neuphoria Therapeutics Inc (NEUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2023 | 12-2022 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -21,439 | N/A | -15,786 | -6,498 |
| Depreciation Amortization | 779 | N/A | 805 | 1,271 |
| Other Working Capital | 4,690 | N/A | -4,064 | 1,220 |
| Other Operating Activity | 1,602 | -5,925 | 3,261 | -1,626 |
| Operating Cash Flow | $-14,368 | $-5,925 | $-15,784 | $-5,633 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | 0 | N/A | 126 | 26 |
| Other Investing Activity | 323 | 126 | 325 | -85 |
| Investing Cash Flow | $323 | $126 | $451 | $-60 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 3,741 | 3,916 | 19,585 | 23,577 |
| Financing Cash Flow | $3,741 | $3,916 | $19,585 | $23,577 |
| Exchange Rate Effect | -5 | -2 | -578 | -10 |
| Beginning Cash Position | 22,596 | 22,076 | 20,676 | 3,420 |
| End Cash Position | 12,286 | 20,190 | 24,351 | 21,295 |
| Net Cash Flow | $-10,310 | $-1,885 | $3,675 | $17,874 |
| Free Cash Flow | ||||
| Operating Cash Flow | -14,368 | -5,925 | -15,784 | -5,633 |
| Free Cash Flow | -14,368 | -5,925 | -15,784 | -5,633 |